Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Progressive Corp (PGR) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance

Progressive CorpTrade
SELLAS Life Sciences Group Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Progressive Corp vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Progressive Corp trades at $218.73 (market cap $124.28B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: Progressive Corp is far larger — about 54.5× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Progressive Corp pays a 0.19% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.

PGRSLS
Market Cap
$124.28B$2.28B
Volume
2,551,1913,128,960
Sector
FinancialsHealth
52-Week High
$242.16$15.46
52-Week Low
$190.40$1.39
Typical Hold Time
81 Days—
Enterprise Value
$132.48B$2.15B
Dividend Yield
0.19%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Progressive Corp

PGR trades at $218.73, up 3.15% today, with a bullish technical signal from moving averages and strong fundamentals including a 12.85% net income margin and 34.94% ROE. Revenue grew from $49.6B in 2022 to $87.6B in 2025, with net income surging to $11.3B. The company recently announced a $0.10 dividend payable in October 2026, and Q2 2026 earnings beat expectations.

The outlook is positive given robust earnings growth and analyst consensus price target of $222.23, though risks include intensifying competition in personal auto insurance and potential market volatility. Institutional interest remains strong with recent position increases by funds like QRG Capital Management.

SELLAS Life Sciences Group Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PGR
3% Buy97% Sell
Avg holding period · 81 Days
SLS

No sentiment data available yet.

About Progressive Corp

Progressive underwrites private and commercial auto insurance and specialty lines

Read more on PGR →

About SELLAS Life Sciences Group Inc. Common Stock

SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.

Read more on SLS →